Zhejiang Hisun Pharmaceutical's Subsidiaries Obtain Veterinary Drug Approval Certificates

Stock News2025-12-23

Zhejiang Hisun Pharmaceutical Co.,Ltd. (600267.SH) announced that its subsidiaries, Zhejiang Hisun Animal Health Co., Ltd. ("Hisun Animal Health") and Yunnan Biological Pharmaceutical Co., Ltd. ("Yunnan Biological"), a wholly-owned subsidiary of Hisun Animal Health, have received veterinary drug approval certificates issued by the Ministry of Agriculture and Rural Affairs of China.

The approvals cover Doxycycline Hyclate Tablets and Swine Fever Virus E2 Protein Recombinant Baculovirus Inactivated Vaccine (WH-09 Strain). These approvals will further enrich the company's product portfolio in veterinary drugs and vaccines, supporting its strategic expansion in the veterinary pharmaceutical sector and enhancing market competitiveness.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181896611?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-23 17:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181896611","market":"nz","top_or_hot":-1,"title":"Zhejiang Hisun Pharmaceutical's Subsidiaries Obtain Veterinary Drug Approval Certificates","media":"Stock News","content":"<p>Zhejiang Hisun Pharmaceutical Co.,Ltd. (600267.SH) announced that its subsidiaries, Zhejiang Hisun Animal Health Co., Ltd. (\"Hisun Animal Health\") and Yunnan Biological Pharmaceutical Co., Ltd. (\"Yunnan Biological\"), a wholly-owned subsidiary of Hisun Animal Health, have received veterinary drug approval certificates issued by the Ministry of Agriculture and Rural Affairs of China.</p>\n<p>The approvals cover Doxycycline Hyclate Tablets and Swine Fever Virus E2 Protein Recombinant Baculovirus Inactivated Vaccine (WH-09 Strain). These approvals will further enrich the company's product portfolio in veterinary drugs and vaccines, supporting its strategic expansion in the veterinary pharmaceutical sector and enhancing market competitiveness.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zhejiang Hisun Pharmaceutical's Subsidiaries Obtain Veterinary Drug Approval Certificates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZhejiang Hisun Pharmaceutical's Subsidiaries Obtain Veterinary Drug Approval Certificates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-23 17:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhejiang Hisun Pharmaceutical Co.,Ltd. (600267.SH) announced that its subsidiaries, Zhejiang Hisun Animal Health Co., Ltd. (\"Hisun Animal Health\") and Yunnan Biological Pharmaceutical Co., Ltd. (\"Yunnan Biological\"), a wholly-owned subsidiary of Hisun Animal Health, have received veterinary drug approval certificates issued by the Ministry of Agriculture and Rural Affairs of China.</p>\n<p>The approvals cover Doxycycline Hyclate Tablets and Swine Fever Virus E2 Protein Recombinant Baculovirus Inactivated Vaccine (WH-09 Strain). These approvals will further enrich the company's product portfolio in veterinary drugs and vaccines, supporting its strategic expansion in the veterinary pharmaceutical sector and enhancing market competitiveness.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0060","symbol_name":"抗癌","start_time":0,"source_url":"","article_id":"1181896611","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181896611","pubTimestamp":1766481621,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Zhejiang Hisun Pharmaceutical Co.,Ltd. (600267.SH) announced that its subsidiaries, Zhejiang Hisun Animal Health Co., Ltd. (\"Hisun Animal Health\") and Yunnan Biological Pharmaceutical Co., Ltd....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600267":"海正药业","BK0060":"抗癌","BK0028":"国家队","BK0239":"医药制造","BK0188":"融资融券"},"translate_title":"浙江海正药业子公司获兽药批准证书","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600267":1},"content_text":"Zhejiang Hisun Pharmaceutical Co.,Ltd. (600267.SH) announced that its subsidiaries, Zhejiang Hisun Animal Health Co., Ltd. (\"Hisun Animal Health\") and Yunnan Biological Pharmaceutical Co., Ltd. (\"Yunnan Biological\"), a wholly-owned subsidiary of Hisun Animal Health, have received veterinary drug approval certificates issued by the Ministry of Agriculture and Rural Affairs of China.\nThe approvals cover Doxycycline Hyclate Tablets and Swine Fever Virus E2 Protein Recombinant Baculovirus Inactivated Vaccine (WH-09 Strain). These approvals will further enrich the company's product portfolio in veterinary drugs and vaccines, supporting its strategic expansion in the veterinary pharmaceutical sector and enhancing market competitiveness.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181896611","isCrawlerRequest":true}